Food Safety Incidents

Products offered as being slimming has been detected in Dietary supplement glamorous ozem.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Food Safety Incident Report

On February 12, 2026, a significant food safety incident was reported concerning a dietary supplement marketed for slimming purposes. The Brazilian Health Regulatory Agency (ANVISA) has identified issues related to the product, which has raised concerns about its safety and efficacy.

The dietary supplement in question, referred to generically as a slimming dietary supplement, was found to contain ingredients that may not be compliant with health regulations. This incident highlights the importance of rigorous control measures in the dietary supplement industry, particularly for products that claim to assist with weight loss.

Consumers are advised to exercise caution when considering dietary supplements, especially those that promise rapid results. It is crucial to verify the safety and regulatory compliance of such products before consumption. The Brazilian Health Regulatory Agency is actively investigating the matter to ensure that public health is safeguarded and that any harmful products are removed from the market.

As this situation develops, further updates will be provided to inform the public about the safety of dietary supplements and the actions being taken to address any potential risks associated with these products. Consumers are encouraged to report any adverse effects or concerns related to dietary supplements to health authorities.

  • Incident: Products offered as being slimming has been detected in Dietary supplement glamorous ozem.
  • Date: 2026-02-12
  • Product: Dietary supplement glamorous ozem
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA